113 related articles for article (PubMed ID: 31596134)
1. Serum DKK1 is correlated with γ peak of serum electrophoresis in multiple myeloma: a multicenter biomarker study.
Hashemi ZS; Khalili S; Malaei F; Mard-Soltani M; Jafarisani M; Lotfi J; Deemeh MR; Zakeri A; Rasaee MJ
Biomark Med; 2019 Oct; 13(15):1297-1306. PubMed ID: 31596134
[No Abstract] [Full Text] [Related]
2. Correlations of DKK1 with pathogenesis and prognosis of human multiple myeloma.
Feng Y; Zhang Y; Wei X; Zhang Q
Cancer Biomark; 2019; 24(2):195-201. PubMed ID: 30614800
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation.
Politou MC; Heath DJ; Rahemtulla A; Szydlo R; Anagnostopoulos A; Dimopoulos MA; Croucher PI; Terpos E
Int J Cancer; 2006 Oct; 119(7):1728-31. PubMed ID: 16646053
[TBL] [Abstract][Full Text] [Related]
4. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
[TBL] [Abstract][Full Text] [Related]
5. DKK1 and sclerostin are early markers of relapse in multiple myeloma.
Mabille C; Ruyssen-Witrand A; Degboe Y; Gennero I; Loiseau HA; Roussel M; Hebraud B; Nigon D; Attal M; Laroche M
Bone; 2018 Aug; 113():114-117. PubMed ID: 28993177
[TBL] [Abstract][Full Text] [Related]
6. Serum Dickkopf-1 acts as a new biomarker in human breast cancer.
Liu JT; Guo WB; Sun JY
Minerva Med; 2017 Aug; 108(4):334-340. PubMed ID: 28248066
[TBL] [Abstract][Full Text] [Related]
7. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
[TBL] [Abstract][Full Text] [Related]
8. [Bone marrow plasma concentrations of Dickkopf1 in patients with multiple myeloma].
Dun XY; Jiang H; Hou J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 38(5):453-8. PubMed ID: 19830856
[TBL] [Abstract][Full Text] [Related]
9. Combination of DKK1 and AFP improves diagnostic accuracy of hepatocellular carcinoma compared with either marker alone.
Erdal H; Gül Utku Ö; Karatay E; Çelik B; Elbeg Ş; Doğan İ
Turk J Gastroenterol; 2016 Jul; 27(4):375-81. PubMed ID: 27458854
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum and tissue Dickkopf-1 levels in patients with gastric cancer.
Lee HS; Lee HE; Park DJ; Kim HH; Kim WH; Park KU
Clin Chim Acta; 2012 Nov; 413(21-22):1753-60. PubMed ID: 22796372
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel combined biomarkers in the diagnosis of multiple myeloma.
Jin Y; Liang Y; Su Y; Hui L; Liu H; Ding L; Zhou F
Hematology; 2021 Dec; 26(1):964-969. PubMed ID: 34871540
[TBL] [Abstract][Full Text] [Related]
12. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
13. Strong immunoexpression of dickkopf-1 is associated with response to bortezomib in multiple myeloma.
Choi YW; Park JS; Han JH; Kim JH; Ahn MS; Lee HW; Kang SY; Choi JH; Jeong SH
Leuk Lymphoma; 2018 Nov; 59(11):2670-2678. PubMed ID: 29582699
[TBL] [Abstract][Full Text] [Related]
14. High apelin levels could be used as a diagnostic marker in multiple myeloma: A comparative study.
Maden M; Pamuk ON; Pamuk GE
Cancer Biomark; 2016; 17(4):391-396. PubMed ID: 27689615
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
Ščudla V; Petrová P; Pika T; Lochman P; Minařík J; Bačovský J; Srovnalík K
Cas Lek Cesk; 2015; 154(4):181-8. PubMed ID: 26357861
[TBL] [Abstract][Full Text] [Related]
16. Cyclized Oligopeptide Targeting LRP5/6-DKK1 Interaction Reduces the Growth of Tumor Burden in a Multiple Myeloma Mouse Model.
Park BM; Kim EJ; Nam HJ; Zhang D; Bae CH; Kang M; Kim H; Lee W; Bogen B; Lim SK
Yonsei Med J; 2017 May; 58(3):505-513. PubMed ID: 28332354
[TBL] [Abstract][Full Text] [Related]
17. Long-term prognostic impact of osteopontin and Dickkopf-related protein 1 in patients with hepatocellular carcinoma after hepatectomy.
Byeon H; Lee SD; Hong EK; Lee DE; Kim BH; Seo Y; Joo J; Han SS; Kim SH; Park SJ
Pathol Res Pract; 2018 Jun; 214(6):814-820. PubMed ID: 29753515
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma.
Heath DJ; Chantry AD; Buckle CH; Coulton L; Shaughnessy JD; Evans HR; Snowden JA; Stover DR; Vanderkerken K; Croucher PI
J Bone Miner Res; 2009 Mar; 24(3):425-36. PubMed ID: 19016584
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue growth factor is an indicator of bone involvement in multiple myeloma, but matrix metalloproteinase-9 is not.
Munemasa S; Sakai A; Kuroda Y; Okikawa Y; Katayama Y; Asaoku H; Kubo T; Miyakawa Y; Serikawa M; Sasaki T; Kimura A
Br J Haematol; 2007 Oct; 139(1):41-50. PubMed ID: 17854305
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer.
Sheng SL; Huang G; Yu B; Qin WX
Clin Chem; 2009 Sep; 55(9):1656-64. PubMed ID: 19628661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
